Galit Zuckerman Stark
Founder, CEO and board member
Before founding Medasense she led algorithm teams at Applied Materials and worked at Nokia-Siemens and Nice Systems. Ms. Zuckerman started her technology career at the elite Israeli Defense Forces “Haman Talpiot” program. She also served as a consultant for several start-up companies in the field of signal and image processing including BoneTone Communications which was successfully acquired by DSPG Inc in 2011.
Ms. Zuckerman Stark holds an MSc degree in Electrical Engineering (cum laude, Engineering Faculty Excellence Program) and a BSc in Computer Engineering (cum laude, Adi Lautman special program for outstanding students TAU) from Tel Aviv University, Israel.
Previously Mr. Tabachnik has held a number of senior accounting positions in various distinguished firms in Israel and South Africa. Mr. Tabachnik is a Certified Public Accountant in Israel and holds a BA in Accounting and Economics from the Hebrew University of Jerusalem, Israel.
VP Research and Development
He was previously the Algorithm Group Manager for Applied Materials where he developed several unique Intellectual Property solutions with patents filed and his work published. Prior to this, he has held software engineering roles for Demantra-Oracle and Idioma.
Mr. Costa holds an MSc in Computer Sciences from Bar-Ilan University, Israel.
VP Business Development & Marketing
She led the trade and sales activity in the U.S. and Europe and was responsible for the strategic business partnerships. She has also held various business development and marketing leadership positions for Ophir Group and Promarket.
Ms. Sofer served as an outside director of a public company and holds an EMBA from the Recanati Business School – Tel Aviv University
VP Clinical, Regulatory and QA Affairs
Ms. Weissbrod has held leadership roles in Quality Assurance, Regulatory & Clinical Affairs at Covidien, Oridion Medical and additional start-up companies with extensive experience in leading teams in the development and execution of global regulatory, quality and clinical strategies supporting new product development and commercialization.
Ms. Weissbrod holds a B.Pharm, and an MBA, both from the Hebrew University, Jerusalem, Israel.